Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001493152-21-014430
Filing Date
2021-06-15
Accepted
2021-06-15 17:06:56
Documents
28

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2713865
2 filename2.htm EX-3.2 13692
3 filename3.htm EX-4.1 140898
4 filename4.htm EX-10.1 161006
5 logo_001.jpg GRAPHIC 7906
6 figure01_01.jpg GRAPHIC 18814
7 figure02_01.jpg GRAPHIC 128479
8 figure03_01.jpg GRAPHIC 325033
9 figure04_01.jpg GRAPHIC 176854
10 figure06_01.jpg GRAPHIC 131910
11 figure07_01.jpg GRAPHIC 110384
12 figure07_02.jpg GRAPHIC 138190
13 figure05_01.jpg GRAPHIC 190604
14 figure08_01.jpg GRAPHIC 120168
15 figure09_01.jpg GRAPHIC 88222
16 figure10_01.jpg GRAPHIC 21809
17 figure11_01.jpg GRAPHIC 174005
18 figure12_01.jpg GRAPHIC 71622
19 figure13_01.jpg GRAPHIC 103898
20 figure14_01.jpg GRAPHIC 102828
21 figure15_01.jpg GRAPHIC 96511
22 figure16_01.jpg GRAPHIC 83018
23 figure17_01.jpg GRAPHIC 82111
24 figure18_01.jpg GRAPHIC 106743
25 figure19_01.jpg GRAPHIC 89753
26 figure20_01.jpg GRAPHIC 97710
27 figure21_01.jpg GRAPHIC 90793
28 figure22_01.jpg GRAPHIC 120336
  Complete submission text file 0001493152-21-014430.txt   6720218
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-04576 | Film No.: 211019353
SIC: 2834 Pharmaceutical Preparations